Related Experiment Video
Updated: Apr 6, 2026
09:20
Lumped-Parameter and Finite Element Modeling of Heart Failure with Preserved Ejection Fraction
Published on: February 13, 2021
7.2K
Modeling and Simulation Approaches for Cardiovascular Function and Their Role in Safety Assessment
T A Collins1, L Bergenholm2, T Abdulla2
1Drug Safety and Metabolism, AstraZeneca Alderley Park, Macclesfield, UK.
CPT: Pharmacometrics & Systems Pharmacology
|July 31, 2015
Summary
Systems pharmacology modeling and pharmacokinetic-pharmacodynamic (PK/PD) analysis are vital for assessing drug safety. This review covers current modeling and simulation (M&S) approaches for drug-induced cardiovascular effects and suggests future research directions.
Area of Science:
- Pharmacology
- Drug Safety
- Computational Biology
Background:
- Cardiovascular (CV) safety is a critical concern in new drug development.
- Understanding drug-induced CV effects is essential for risk assessment.
Purpose of the Study:
- To review current modeling and simulation (M&S) approaches for drug-induced CV effects.
- To emphasize the impact of these approaches on drug safety assessment.
- To identify limitations and propose future research directions.
Main Methods:
- Review of existing systems pharmacology models.
- Analysis of pharmacokinetic-pharmacodynamic (PK/PD) modeling techniques.
- Evaluation of M&S strategies for translating preclinical data to clinical CV outcomes.
Main Results:
- Current M&S approaches provide valuable insights into drug-induced CV effects.
- PK/PD modeling is a key tool for predicting and understanding these effects.
- Limitations exist in current methodologies for comprehensive safety assessment.
Conclusions:
- M&S of drug-induced CV effects is crucial for drug safety.
- Further research is needed to refine methodologies and address current limitations.
- Enhanced predictive models will improve the safety evaluation of novel therapeutics.
